WebApr 12, 2024 · Myriad Genetics Inc CIK: 899923 Ticker: MYGN GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies WebApr 6, 2024 · Myriad Genetics, Inc. – Filings and Transcripts – BamSEC Myriad Genetics, Inc. Watch NASDAQ: MYGN Share price (4/6/23): $23.33 Market cap (4/6/23): $1.895 billion 4 Myriad Genetics, Inc. Expert Interviews, now on BamSEC. Powered by Tegus. See All MYGN Interviews Financials Filter 10-K ended 12/31/22 FY 2024 03/01/23 10-Q ended …
0001564590-20-040011 10-K Myriad Genetics, Inc.
WebApr 15, 2024 · The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Myriad Genetics news, COO Nicole Lambert sold 6,433 … WebMar 27, 2024 · Ronald Blue Trust Inc. raised its position in Myriad Genetics, Inc. ( NASDAQ:MYGN - Get Rating) by 103.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,028 shares of the company's stock after buying an additional 4,589 shares during the … task force khatarnak khalnayak episode 55
Myriad Interactive Media, Inc. - sec.gov
WebAug 13, 2014 · Myriad Genetics Inc (MYGN) SEC Filing 10-K Annual report for the fiscal year ending Monday, June 30, 2014. Home. SEC Filings. Myriad Genetics Inc (MYGN) ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat … WebMar 13, 2024 · The institutional investor owned 14,583,195 shares of the company's stock after selling 175,205 shares during the quar BlackRock Inc. trimmed its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Get Rating) by 1.2% in the 3rd quarter, according to its most recent disclosure with the SEC. WebApr 9, 2024 · Myriad Genetics Price Performance Shares of MYGN opened at $23.33 on Friday. The firm has a 50-day simple moving average of $21.22 and a two-hundred day simple moving average of $19.52. The stock has a market cap of $1.89 billion, a PE ratio of -16.78 and a beta of 1.84. Myriad Genetics, Inc. has a 1-year low of $13.92 and a 1-year … task force adalah pekerjaan